Global Meningioma Drug Market Survey and Trend Research 2018

June 2018 | 84 pages | ID: GB030F3EA5CEN
99Strategy

Abstracts

Summary

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Arno Therapeutics Inc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Eli Lilly and Co, GlaxoSmithKline Plc, GlaxoSmithKline Plc, Merck & Co Inc, Merck KGaA, Novartis AG, Ono Pharmaceutical Co Ltd, Pharma Mar SA, Progenics Pharmaceuticals Inc etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Meningioma Drug Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 MENINGIOMA DRUG MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Arno Therapeutics Inc (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 AstraZeneca Plc (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Boehringer Ingelheim GmbH (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Eli Lilly and Co (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 GlaxoSmithKline Plc (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 GlaxoSmithKline Plc (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Merck & Co Inc (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Merck KGaA (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Novartis AG (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Ono Pharmaceutical Co Ltd (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Pharma Mar SA (Company Overview, Sales Data etc.)
4.12 Progenics Pharmaceuticals Inc (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

TABLE GLOBAL MENINGIOMA DRUG MARKET 2012-2017, BY TYPE, IN USD MILLION

Table Global Meningioma Drug Market 2012-2017, by Type, in Volume
Table Global Meningioma Drug Market Forecast 2018-2023, by Type, in USD Million
Table Global Meningioma Drug Market Forecast 2018-2023, by Type, in Volume
Table Arno Therapeutics Inc Overview List
Table Meningioma Drug Business Operation of Arno Therapeutics Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Plc Overview List
Table Meningioma Drug Business Operation of AstraZeneca Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim GmbH Overview List
Table Meningioma Drug Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly and Co Overview List
Table Meningioma Drug Business Operation of Eli Lilly and Co (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Plc Overview List
Table Meningioma Drug Business Operation of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Plc Overview List
Table Meningioma Drug Business Operation of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co Inc Overview List
Table Meningioma Drug Business Operation of Merck & Co Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck KGaA Overview List
Table Meningioma Drug Business Operation of Merck KGaA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis AG Overview List
Table Meningioma Drug Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ono Pharmaceutical Co Ltd Overview List
Table Meningioma Drug Business Operation of Ono Pharmaceutical Co Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pharma Mar SA Overview List
Table Meningioma Drug Business Operation of Pharma Mar SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Progenics Pharmaceuticals Inc Overview List
Table Meningioma Drug Business Operation of Progenics Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Meningioma Drug Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Meningioma Drug Sales Revenue Share, by Companies, in USD Million
Table Global Meningioma Drug Sales Volume 2012-2017, by Companies, in Volume
Table Global Meningioma Drug Sales Revenue Share, by Companies in 2017, in Volume
Table Meningioma Drug Demand 2012-2017, by Application, in USD Million
Table Meningioma Drug Demand 2012-2017, by Application, in Volume
Table Meningioma Drug Demand Forecast 2018-2023, by Application, in USD Million
Table Meningioma Drug Demand Forecast 2018-2023, by Application, in Volume
Table Global Meningioma Drug Market 2012-2017, by Region, in USD Million
Table Global Meningioma Drug Market 2012-2017, by Region, in Volume
Table Meningioma Drug Market Forecast 2018-2023, by Region, in USD Million
Table Meningioma Drug Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Meningioma Drug Industry Chain Structure
Figure Global Meningioma Drug Market Growth 2012-2017, by Type, in USD Million
Figure Global Meningioma Drug Market Growth 2012-2017, by Type, in Volume
Figure Global Meningioma Drug Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Meningioma Drug Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region